Maria Zannes - Apr 8, 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
President & CEO
Signature
/s/ Maria Zannes
Stock symbol
BIAF
Transactions as of
Apr 8, 2024
Transactions value $
$324
Form type
4
Date filed
4/24/2024, 04:00 PM
Previous filing
Feb 2, 2024
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Options Exercise $75.2K +64.8K +39.38% $1.16 230K Apr 8, 2024 Direct
transaction BIAF Common Stock Tax liability -$74.9K -28.3K -12.32% $2.65 201K Apr 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIAF Stock Option (right to buy) Options Exercise $0 -64.8K -100% $0.00* 0 Apr 8, 2024 Common Stock 64.8K $1.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover the exercise price of the options exercised.
F2 This option vested in 7 equal monthly installments beginning on April 28, 2014.